Tech & Pharma
AB SCIEX has announced the opening of a new research and development center in Singapore.
The inaugural Tech Transfer Summit Asia will take place from December 5-6, 2013 at the Grand Copthorne Waterfront Hotel Singapore.
BioChain and Epigenomics AG have announced a collaboration to bring Epigenomics’ Septin9 colorectal cancer screening technology to China.
Bristol-Myers Squibb and Kyowa Hakko Kirin will commercialize Coniel, a calcium channel blocker for the treatment of hypertension and angina pectoris, in China.
3SBio Inc. has acquired patents for DJ5 to develop DJ5 as a treatment for progressive renal failure in patients with autosomal dominant polycystic kidney disease.
In January 2014, Singapore will host the inaugural EmTech Singapore, an edition of the world’s most prestigious technology conference for the very first time.
The China National Genebank has formed an alliance with BioStorage Technologies, which will provide it with biorepository expertise for the development of the biobank.
Taiwanese vaccine maker Adimmune Corp has received approval from the Chinese government to start Phase III clinical trials of its flu vaccine in China.
Kindstar will validate and implement ACD’s RNAscope® technology-based molecular diagnostic assays in its clinical laboratories.
Singapore’s Nanyang Technological University has launched a cryo-electron microscopy lab to study molecular structures half a million times smaller than a grain of rice.